Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Patient Comfort × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Multidisciplinary Collaborative 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Neoplasm 1

Interventions

Dexamethasone 677 Bortezomib 381 Lenalidomide 364 Cyclophosphamide 289 Melphalan 220 Calcium Dobesilate 200 daratumumab 187 pomalidomide 163 carfilzomib 146 Thalidomide 103 fludarabine 101 fludarabine phosphate 97 Peripheral Blood Stem Cell Transplantation 97 Filgrastim 96 ixazomib 75 Whole-Body Irradiation 69 Granulocyte Colony-Stimulating Factor 69 dexamethasone acetate 67 Busulfan 66 Mycophenolic Acid 65 Tacrolimus 59 dexamethasone 21-phosphate 56 Prednisone 55 Cyclosporine 53 auricularum 52 isatuximab 51 elotuzumab 50 belantamab mafodotin 49 Antilymphocyte Serum 47 Etoposide 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡